Rongde Cheng

Title: **Rongde Cheng: Innovator in Pharmaceutical Chemistry**

Introduction

Rongde Cheng, based in Taizhou, China, is a notable inventor recognized for his contributions to pharmaceutical chemistry. With a specific focus on the synthesis of complex compounds, he has made a significant impact in the development of important medications.

Latest Patents

Rongde Cheng holds a patent for a novel method for preparing Aliskiren and its intermediates. This invention outlines a detailed procedure that includes several critical steps: the reaction of 4-bromo-1-methoxy-2-(3-methoxypropoxy)benzene with magnesium isopropyl chloride and n-BuLi to create a compound (designated as formula XXII), followed by additional transformations to yield the intermediate for Aliskiren. His innovative approach involves using an ether solvent and an iron-containing catalyst, culminating in the successful synthesis of Aliskiren.

Career Highlights

Cheng is part of the team at Zhejiang Tianyu Pharmaceutical Co., Ltd., a company dedicated to advancing pharmaceutical research and development. His work in developing efficient methods for drug synthesis showcases his expertise and commitment to improving healthcare solutions.

Collaborations

During his career, Rongde Cheng has collaborated with several colleagues, including Yongjun Tu and Yi Zhang. These collaborations have undoubtedly enriched his work and contributed to the success of their collective projects in the pharmaceutical industry.

Conclusion

Rongde Cheng exemplifies the innovative spirit of today's scientists and inventors. His patent for the method of preparing Aliskiren underscores his significant role in the field of pharmaceutical chemistry, and his ongoing collaborations suggest a promising future for further innovations.